Advertisement
UK markets close in 2 hours 10 minutes
  • FTSE 100

    8,075.90
    +31.09 (+0.39%)
     
  • FTSE 250

    19,765.10
    -34.62 (-0.17%)
     
  • AIM

    755.11
    +0.24 (+0.03%)
     
  • GBP/EUR

    1.1640
    +0.0013 (+0.11%)
     
  • GBP/USD

    1.2449
    -0.0004 (-0.03%)
     
  • Bitcoin GBP

    53,094.65
    -36.63 (-0.07%)
     
  • CMC Crypto 200

    1,429.32
    +5.22 (+0.37%)
     
  • S&P 500

    5,070.55
    +59.95 (+1.20%)
     
  • DOW

    38,503.69
    +263.71 (+0.69%)
     
  • CRUDE OIL

    82.97
    -0.39 (-0.47%)
     
  • GOLD FUTURES

    2,337.00
    -5.10 (-0.22%)
     
  • NIKKEI 225

    38,460.08
    +907.92 (+2.42%)
     
  • HANG SENG

    17,201.27
    +372.34 (+2.21%)
     
  • DAX

    18,144.97
    +7.32 (+0.04%)
     
  • CAC 40

    8,131.20
    +25.42 (+0.31%)
     

Novartis’s Innovative Medicines Segment in 2016

Novartis’s Innovative Medicines segment, formerly referred to as its Pharmaceuticals segment, consists of products for therapeutic areas including oncology, respiratory, and established medicines.